Literature DB >> 7901042

Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures.

W E Müller1, H Ushijima, H C Schröder, J M Forrest, W F Schatton, P G Rytik, M Heffner-Lauc.   

Abstract

Rat cortical cells were incubated with the Scrapie prion protein, PrionSc. At concentrations of 3 ng/ml of PrionSc and higher, the viability of the cells decreased significantly after a 12-h incubation period. Simultaneously, the degree of DNA fragmentation increased. In control experiments with antibodies against PrionSc, PrionSc lost its deleterious effect on neurons. PrionSc did not affect the viability of astrocytes. Drugs known to block NMDA receptor channels, such as memantine (1-amino-3,5-dimethyl-adamantane) (Mem), its analogue 1-N-methylamino-3,5-dimethyl-adamantane as well as (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK-801) prevented the effect of PrionSc. Production of PrionSc in the Scrapie prion-infected subclone of N2 a cells (ScN2 a cells) was not affected by memantine. We conclude that antagonists of the NMDA receptor-channel complex (i) abolish the PrionSc-induced neuronal injury in vitro, and (ii) display no influence on the synthesis and/or the processing of PrionSc.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901042     DOI: 10.1016/0922-4106(93)90040-g

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  24 in total

Review 1.  Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders.

Authors:  Peter K Stys; Haitao You; Gerald W Zamponi
Journal:  J Physiol       Date:  2012-02-06       Impact factor: 5.182

2.  The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.

Authors:  Ulrike K Resenberger; Anja Harmeier; Andreas C Woerner; Jessica L Goodman; Veronika Müller; Rajaraman Krishnan; R Martin Vabulas; Hans A Kretzschmar; Susan Lindquist; F Ulrich Hartl; Gerd Multhaup; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  EMBO J       Date:  2011-03-25       Impact factor: 11.598

3.  Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases.

Authors:  Elisa Meneghetti; Lisa Gasperini; Tommaso Virgilio; Fabio Moda; Fabrizio Tagliavini; Federico Benetti; Giuseppe Legname
Journal:  Mol Neurobiol       Date:  2019-02-01       Impact factor: 5.590

4.  Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial Cells.

Authors:  Valentina Villa; Stefano Thellung; Alessandro Corsaro; Federica Novelli; Bruno Tasso; Luca Colucci-D'Amato; Elena Gatta; Michele Tonelli; Tullio Florio
Journal:  Mol Neurobiol       Date:  2014-11-18       Impact factor: 5.590

5.  Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals.

Authors:  R Demaimay; K T Adjou; V Beringue; S Demart; C I Lasmézas; J P Deslys; M Seman; D Dormont
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.

Authors:  N Kellershohn; M Laurent
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

7.  Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3.

Authors:  Mar Pérez; Ana I Rojo; Francisco Wandosell; Javier Díaz-Nido; Jesús Avila
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

8.  Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation.

Authors:  Hung-Ming Wu; Nian-Sheng Tzeng; Li Qian; Sung-Jen Wei; Xiaoming Hu; Shih-Heng Chen; Scott M Rawls; Patrick Flood; Jau-Shyong Hong; Ru-Band Lu
Journal:  Neuropsychopharmacology       Date:  2009-06-17       Impact factor: 7.853

Review 9.  Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease.

Authors:  I Ferrer
Journal:  Cerebellum       Date:  2002-07       Impact factor: 3.847

10.  Immunopurification of pathological prion protein aggregates.

Authors:  Emiliano Biasini; Laura Tapella; Susanna Mantovani; Matteo Stravalaci; Marco Gobbi; David A Harris; Roberto Chiesa
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.